Chemed (NYSE: CHE) is higher today on more deal speculation after the rival of its Vitas Healthcare unit, Odyssey Healthcare ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE